Radar Vectors
FAA Order Cancelled Issued Aug 9, 2018 AAM-820 105 pages Copy saved Nov 18, 2026

Order 9120.1D Drug and Alcohol Compliance and Enforcement Inspector Handbook - Including Change 1

This order documents the procedures used by Federal Aviation Administration (FAA) drug and alcohol compliance and enforcement inspectors and investigators to assess the compliance of aviation industry employers, contractors and service agents with the requirements in the Code of Federal Regulations (CFR). Specifically, the regulatory requirements including the Department of Transportation’s (DOT) 49 CFR part 40, “Procedures for Transportation Workplace Drug and Alcohol Testing Programs;” the FAA’s 14 CFR part 120, “Drug and Alcohol Testing Program;” and other relevant Federal Aviation Regulations. This order is used in conjunction with FAA’s “Compliance and Enforcement Program” (Order 2150.3, as amended) and “Safety Risk Management Policy” (Order 8040.4, as amended) to ensure that inspections and investigations are conducted accurately, fairly, and consistently throughout the Drug Abatement Division.

This document is cancelled. Cancelled by 9120.1E. Check the official source before relying on it.

Official source ↗ Open PDF

Text read by OCR from a scanned file (1 of 105 pages). Check the original, as some words may be misread.

PAGE CHANGE CONTROL CHART

Change U.S. DEPARTMENT OF TRANSPORTATION

FEDERAL AVIATION ADMINISTRATION

ORDER 9120.1D CHG 1

Effective Date:

04/30/2019 National Policy

SUBJ: Changes to Administrative and Legal Enforcement Actions Based on Update to FAA

Order 2150.3C, FAA Compliance and Enforcement Program

1. Purpose. This change harmonizes FAA Order 9120.1D with the updated FAA Order 2150.3C, FAA Compliance and Enforcement Program, published September 18, 2018. Changes include updated guidance on the collection, preservation and authentication of evidence, updated guidance on assembling the Enforcement Investigative Report (EIR) and what information must be included in Section B, and the new method of determining punitive sanctions. This change also incorporates FAA Order 8000.373A,published October 31, 2018, which sets forth overarching guidance for implementing the FAA Compliance Program (previously referred to as the Compliance Philosophy).

2. Who this change affects. The change affects all Drug Abatement Division personnel, particularly those who investigate, report, or process enforcement actions involving violations of the industry drug and alcohol testing requirements in the Federal Aviation Regulations.

3. Disposition of Transmittal Paragraph. Retain this transmittal sheet until the directive is cancelled by a new directive.

PAGE CHANGE CONTROL CHART

Insert Pages Dated 2 04/30/2019 10 04/30/2019 13 04/30/2019 17-25 04/30/2019 35 04/30/2019 46-48 04/30/2019 51 04/30/2019 A-7 04/30/2019 C-5 04/30/2019 F-2 04/30/2019

Remove Pages Dated 2 08/09/2018 10 08/09/2018 13 08/09/2018 17-25 08/09/2018 35 08/09/2018 46-48 08/09/2018 51 08/09/2018 A-7 08/09/2018 C-5 08/09/2018 F-2 08/09/2018

Distribution: Electronic Initiated By: AAM-820

4. Administrative Information. This Order change is distributed to the Drug Abatement Division branches in Washington headquarters, regions, and centers.

Signature Michael A. Berry, M.D. Federal Air Surgeon Aviation Safety

ORDER9120.lD

FAA Logo

U.S. DEPARTMENT OF TRANSPORTATION

FEDERAL AVIATION ADMINISTRATION ORDER

9120.lD

Effective Date:

08/09/2018

SUBJ : Drug and Alcohol Compliance and Enforcement Inspector Handbook The Federal Aviation Administration (FAA), Office of Aerospace Medicine (AAM) has prepared this order for Drug Abatement Division (AAM-800) personnel to follow when inspecting and investigating the drug and alcohol testing program of aviation industry employers, contractors, and individuals for compliance with the provisions of 49 CFR part 40, "Procedures for Transportation Workplace Drug Testing Programs;" and 14 CFR part 120, "Drug and Alcohol Testing Program."

Unless otherwise directed by the Drug Abatement Division Manager, inspectors and investigators must adhere to the procedures in this order. The FAA invites comments and suggestions from those who use the order. Input should be submitted to:

Federal Aviation Administration Office of Aerospace Medicine Drug Abatement Division (AAM-800) 800 Independence A venue, S. W. Washington, D.C. 20591 Sig nature Michael A. Berry, M.D. Federal Air Surgeon

D istribution: Electronically Initiated By: AAM-820

Table of Contents Chapter 1. General Information 1. Purpose of this Order … 4 2. Audience … 4 3. Where Can I Find this Order? … 4 4. What this Order Cancels … 4 5. Inspection Authority … 4 6. Objectives of the Inspection and Investigation Process … 4 7. Who Do We Inspect? … 4

Table of Contents

Chapter 2. Inspection 1. General … 7 2. Inspection Scheduling … 7 3. Preparation for the Inspection … 10 4. Travel Requirements … 11 5. Final Inspection Work Plan … 11 6. Pre-Inspection Team Meetings … 11 7. On-Site Inspection Activities … 11 8. Evidence Collection … 17 9. Documentation of Inspection Results … 18 10. Inspection Conclusion … 19 11. Post Inspection Activities … 20 Figure 2-1 Inspection Schedule Sample … 26 Figure 2-2 Inspection Process Guide … 30 Figure 2-3. Inbriefing/Outbriefing Guide … 31 Figure 2-4. Meeting Attendance List … 32 Figure 2-5. New Hire/Transfer Guide … 33 Figure 2-6. Inspection Compliance Issue Guide … 34 Figure 2-7. Sample Statement of Authenticity … 35 Figure 2-8. Employee Interview Guide … 36 Figure 2-9. Witness Statement Form … 38 Figure 2-10. Record of Interview … 40 Figure 2-11. Inspection Correspondence Flowchart … 41 Figure 2-12. Sample FOUO cover sheet … 42

Chapter 3. Investigations 1. General … 43 2. Sources of Allegations … 43 3. Investigations of a Company … 44 4. Investigations of Individuals Who Perform Safety-Sensitive Functions … 44 5. Individual Violations Discovered During Inspection … 45 6. Pilot’s Bill of Rights … 45

Chapter 4. Voluntary Disclosures 1. General … 46 2. Procedures … 46 Figure 4-1. Sample Inspector/Investigator Analysis … 49

Table of Contents (continued)

Table of Contents (continued)

Chapter 5. Administrative Information 1. Authority to Change this Order … 50 2. Background … 50 3. References … 50

Appendix A. Inspection Guide … A-1

Appendix B. Service Agent Inspection Guide … B-1

Appendix C. Random Drug and Alcohol Testing Job Aid … C-1

Appendix D. Acronyms … D-1

Appendix E. Inspection Scheduling Procedures … E-1

Appendix F. Inspection File Documentation … F-1

Appendix G. Definitions … G-1

Chapter 1. General Information

Chapter 1. General Information

1. Purpose of this Order. This order documents the procedures used by Federal Aviation Administration (FAA) drug and alcohol compliance and enforcement inspectors and investigators to assess the compliance of aviation industry employers, contractors and service agents with the requirements in the Code of Federal Regulations (CFR). Specifically, the regulatory requirements including the Department of Transportation’s (DOT) 49 CFR part 40, “Procedures for Transportation Workplace Drug and Alcohol Testing Programs;” the FAA’s 14 CFR part 120, “Drug and Alcohol Testing Program;” and other relevant Federal Aviation Regulations. This order is used in conjunction with FAA’s “Compliance and Enforcement Program” (Order 2150.3, as amended) and “Safety Risk Management Policy” (Order 8040.4, as amended) to ensure that inspections and investigations are conducted accurately, fairly, and consistently throughout the Drug Abatement Division.

2. Audience. All Drug Abatement Division personnel.

3. Where Can I Find this Order? You can find this order on the MyFAA Employee Web site: https://employees.faa.gov/tools_resources/orders_notices/. This order is available to the public at http://rgl.faa.gov.

4. What this Order Cancels. This order cancels Order 9120.1C, FAA Drug and Alcohol Compliance and Enforcement Inspector Order, dated October 22, 2015.

5. Inspection Authority. The Omnibus Transportation Employee Testing Act of 1991 (49 USC §§ 45101-45107) and the FAA’s general statutory safety authority outlined in 49 USC §§ 106(g) and 44701 provide the authority to conduct the inspections and investigations described in this order.

6. Objectives of the Inspection and Investigation Process. Ensuring compliance with the drug and alcohol testing regulations is the primary objective of the inspection and investigation process. The safety of the traveling public and integrity of the inspection and investigation process form the foundation of every inspection. The regulations and the inspection and investigation processes balance the privacy interests of aviation employees with the safety mandate to detect and deter illegal drug use and alcohol misuse. Inspections and investigations must be conducted in a constructive, ethical, unbiased, and professional manner. Implementation of the procedural safeguards within Federal regulations and this order will ensure these objectives.

7. Who Do We Inspect? We inspect the following entities in accordance with the drug and alcohol testing regulations, 14 CFR part 120, and 49 CFR part 40:

a. Employers. Part 40 defines an employer as “A person or entity employing one or more employees (including an individual who is self-employed) subject to DOT agency regulations requiring compliance with this part. The term includes an employer’s officers, representatives, and management personnel. Service agents are not employers for the purposes of this part.” Part 120 defines an employer as a part 119 certificate holder with authority to operate under parts 121 and/or 135; an operator as defined in 14 CFR § 91.147; or an air traffic control facility not operated by the FAA, or by or under contract for the U.S. Military.

08/09/18 9120.1D (1) An employer must ensure that individuals hired to perform safety-sensitive functions, directly or by contract (including subcontract at any tier), are subject to drug and alcohol testing.

(2) Employers are responsible for all actions of their officials, representatives, and service agents in carrying out the requirements of the testing regulations.

b. Contractors. Part 120 defines a contractor as, “an individual or company that performs a safety-sensitive function by contract for an employer or another contractor.” There are two options for drug and alcohol testing contractors:

(1) The contractor obtains and implements its own drug and alcohol testing program. If the contractor chooses this option, it must implement the program as if it were the employer.

(2) The employer includes the contractor under its own drug and alcohol testing program.

c. Service Agents. Part 40 defines a service agent as, “Any person or entity, other than an employee of the employer, who provides services to employers and/or employees in connection with DOT drug and alcohol testing requirements.”

(1) A Consortium/Third-Party Administrator (C/TPA) is a service agent that may implement all or portions of the testing program for an employer or contractor.

(2) Service agents may provide the following services:

(a) Urine drug collections, as specimen collectors

(b) Breath alcohol testing, as breath alcohol technicians (BAT)

(c) Alcohol saliva testing, as screening test technicians (STT)

(d) Laboratory1

(e) Medical review officer (MRO) functions

(f) Substance abuse professional (SAP) functions

(3) As part 40 prescribes, service agents are required to comply with all aspects of the regulations. The roles and responsibilities of a service agent are addressed under subpart Q and Appendix F of part 40. Inspections or investigations of any employer or contractor may include a review of its service agent’s practices and procedures. The employer or contractor is responsible for compliance with the regulations even when using a service agent. Therefore, a service agent’s failure to comply with the regulations may result in violations against the employer or contractor.

(4) A service agent may be subject to a public interest exclusion (PIE), as described under subpart R of part 40, for egregious violations of the regulations. If an inspection or investigation results in allegations of egregious violations of the regulations by a service agent, the inspector must immediately report this information to his/her Compliance and Enforcement (C&E) Center Manager.

1 The Department of Health and Human Services is responsible for monitoring certified laboratories.

A determination of whether to initiate an inspection, investigation or PIE is determined by the C&E Center Manager in coordination with the Program Administration Branch Manager and the Division Manager. If an inspection is initiated against the service agent, refer to Appendix B of this order for further instructions.

For purposes of this Order, we use the term company to include employer, contractor or service agent, unless it is specifically described.

Chapter 2. Inspection

Chapter 2. Inspection

1. General. A successful inspection entails accomplishing a sequence of five interrelated activities. This sequence begins with inspection scheduling; proceeds through detailed planning, completion of on-site inspection activities, and reporting of inspection results; and concludes with post-inspection follow-up activities. Inspections are executed according to the procedures established in this chapter. The Drug Abatement Division has established an Inspection Guide, which is found under Appendix A of this order. The Guide must be followed by all inspectors and investigators during each inspection. Deviations from the Inspection Guide are strictly prohibited and failure to follow the procedures in the Guide and this chapter may result in a nonconformity and corrective action (NCA). The Compliance and Enforcement Tracking Subsystem (CETS) Reference List should be used to enter out of compliance issues or concerns into CETS. The CETS Reference List is available on the Drug Abatement Division (AAM-800) QMS Web Site.

2. Inspection Scheduling.

a. The FAA employs a variety of inspection activities to ensure companies comply with the drug and alcohol testing regulations. Prior to the beginning of the fiscal year, the inspection weeks are published in CETS. Before every quarter, the Drug Abatement Division composes a quarterly inspection schedule based on this chapter, Drug Abatement’s Strategic Compliance Monitoring Plan2 (SCMP), and the Memorandum of Understanding (MOU) between the FAA and NATCA. Once the priorities are set, a scheduler from the Program Administration Branch assembles the teams of companies and pre-inspection materials for the national inspection schedule. These procedures are found in Appendix E of this order.

b. The inspection team assignments are made in conjunction with the existing MOU. The Program Administration Branch Manager or designated program analyst is responsible for appointing the inspection lead and identifying whether the inspection will be comprehensive or focused. Additionally, inspectors and investigators will be assigned to participate in high impact, special emphasis, and service agent inspections. Inspectors and investigators are required to access their schedules in CETS.

(1) Comprehensive Inspections. Comprehensive inspections are thorough reviews of all aspects of a company’s drug and alcohol testing program. Although we may sometimes focus emphasis on specific areas based on information concerning potential problems, the overall format of such inspections is standardized in accordance with this order. In some cases, the comprehensive inspection may be conducted without advance notice to the company. The Drug Abatement Division’s Program Administration Branch Manager or C&E Center Manager makes the determination as to whether a comprehensive inspection will be announced or unannounced.

2 The Strategic Compliance Monitoring Plan (SCMP) is the Drug Abatement Division’s policy for scheduling inspections.

(2) Focused Inspections. Under certain circumstances, focused inspections, which are narrow or limited in scope, may be conducted in response to a specific problem. Problems may be identified from any of a variety of information sources, including analyses of prior inspection results, annual testing reports, individual or union complaints, or other alternative means. For example, FAA headquarters may receive complaints concerning improper collection procedures. In that case, an inspection focusing on the company’s collection procedures may be conducted. Focused inspections may involve a single company or entity, as in the example above, or a representative group of companies if information indicates that a problem is widespread. A focused inspection must include the company’s administrative and quality assurance activities and mandatory testing (i.e., Medical Review Officer (MRO) verification, pre-employment, random, post-accident, reasonable cause/suspicion, return to duty, and followup). The determination as to whether a focused inspection will be announced or unannounced is made by the Drug Abatement Division’s Program Administration Branch Manager or C&E Center Manager.

(3) Announced Inspections. An announced inspection requires advance notification to the company. This is accomplished by a person assigned to notify the company in accordance with the procedures in Appendix E of this order. The company is contacted and informed of the scheduled inspection and asked to provide information regarding their size, service agents, new hires, etc. Upon receiving the necessary information, the notifier updates the CETS profile and inspection activity and the communication is added to the inspection profile. Once the notifier finalizes the planned schedule, he or she sends an email to the Center Manager and Program Administration Branch Manager indicating the schedule is set. The program analyst/assistant in the Program Administration Branch retrieves the information in CETS and sends the company a letter of notification (LON) to confirm the pending inspection. The LON template is contained in CETS. The program analyst/assistant, following their procedures, must prepare the LON and attachment generated using the CETS template, and must also document the notification in CETS. In cases where a company is added to the schedule after the work plan is sent to the inspector, the inspector should notify the company of the inspection and send the company an LON as soon as possible.

(a) The LON package, sent by the program analyst/assistant, includes a list of records and documents necessary for inspection and a request for the company’s points of contact. Upon completing the notification task, AAM-810 will provide an initial work plan to the inspectors, C&E Center Manager, Team Coordinators, Administrative Officer, and AAM- 810 Manager. The union representative may request and receive a copy of the work plan(s) upon request.

(b) Prior to the inspection, the inspection lead ensures that the point of contact information has been received from the company and updated in CETS. For larger entities that require a multi- day inspection, the lead inspector prepares the Inspection Schedule (found in Figure 2-1) and distributes it accordingly. During any pre-inspection contact with a company, inspectors should refrain from initiating an inspection prior to on-site arrival. All inspectors and investigators are strictly prohibited from coaching companies or distributing unauthorized documents to them at any time.

(c) There may be instances in which an employer, after receiving an LON, will question the need for an inspection because it has ceased operations under 14 CFR § 119.63, but continues to hold a part 119 certificate with authority to conduct part 121 or 135 operations.

08/09/18 9120.1D Regardless of whether an employer that holds a certificate is exercising the privileges of its certificate, it must be available for inspection. If the employer advises the FAA that it has ceased its operations, the inspector/investigator must contact the employer’s Principal Operations Inspector (POI) or Principal Maintenance Inspector (PMI) to determine whether the employer has surrendered its certificate. That information must then be given to the C&E Center Manager for a determination as to whether the employer will be inspected. The C&E Center Manager will notify and consult with the AAM-810 Branch manager. If an employer which has ceased operations under 14 CFR § 119.63, but has retained its certificate, is unwilling to be inspected, the employer must contact its POI/PMI to surrender its certificate. The inspector/investigator must follow-up with the POI/PMI to ensure that this has been accomplished.

(4) Unannounced Inspections. Unannounced inspections are essential to an effective compliance program. Each inspector may be responsible for conducting unannounced inspections during the fiscal year.

(a) C&E Center Managers may schedule an unannounced inspection for any inspector during any inspection week.

(b) Inspection teams may conduct an unscheduled, unannounced inspection, as time allows, which requires the inspectors to locate companies in their assigned geographical areas.

(c) Preparations for unannounced inspections might include contact with the local Flight Standards District Office (FSDO) to ascertain that the company is still operating and has an active certificate.

(d) Inspection leads inform the C&E Center Manager(s) and other teams in the geographical area, if possible, before conducting unscheduled inspections, to preclude multiple inspection attempts at the same company. The C&E Center Manager will notify and consult with the AAM-810 Branch Manager accordingly.

(e) For all unannounced inspections, the inspection lead or team must not contact the company in advance of the inspection.

(5) High Impact Inspections. High impact inspections are conducted by multiple teams of inspectors and investigators from two or more Drug Abatement offices during a one or twoweek period. This approach permits the concentration of inspector and investigator resources in a planned geographic area and maximizes visibility for the Drug Abatement Program. By involving inspectors and investigators from two or more offices, high impact inspections promote consistency within the inspection process and the application of the regulations, provide cross-training, and permit managers to directly observe and assess an inspector’s/investigator’s performance. During high impact inspection weeks, a meeting is scheduled for inspectors, investigators, and managers to meet and discuss program issues. These discussions provide management with topics to be covered in future inspector and investigator training or identify a need for guidance and/or policy development.

(6) Special Emphasis Inspections. Special emphasis inspections are defined as inspections that are scheduled to focus on one part of the regulations (e.g., MRO, SAP, or collection site review) at a national level.

(7) Service Agent Inspections. Service agent inspections specifically focus on MROs, SAPs,

04/30/19 9120.1D C/TPAs, collectors, and BATs. Service agent inspections are independent inspections and are not related to a specific company inspection. The standard operating procedures (SOP) for service agent inspections are in Appendix B of this order.

(8) Inspection Schedule Changes and Cancellations. While all efforts are made to maintain the inspection schedule as is, at times it is essential to the program to make necessary changes. All requests to change the final inspection schedule must be submitted through the C&E Center Manager to the Program Administration Branch Manager in Washington, DC. Once an inspector’s schedule is established, the inspection planning must begin. Prior to canceling an inspection, the inspector must contact the C&E Center Manager. The C&E Center Manager will notify the AAM-810 Branch Manager accordingly. When a scheduled inspection is cancelled, the cancellation must be documented in CETS.

3. Preparation for the Inspection. The inspection lead is responsible for all planning of the assigned inspections. He/she has a critical role in accomplishing the goals of the inspection, ensuring that all critical aspects of an inspection, including planning and reporting, are accomplished according to established procedures (see inspection process guide in Figure 2-2).

a. The inspection lead examines CETS and the drug and alcohol enforcement history of each company to find past noncompliance issues and current potential noncompliance issues (NCTs). This includes previous inspections, open or closed voluntary disclosures, NCTs, and other special issues. This information will help the inspection team identify repeated noncompliance.

b. At a minimum, each inspection will include a review of mandatory testing records (e.g., pre- employment and random testing, positive drug tests, alcohol violations, and refusals), MRO verification, and the records specified in 49 CFR § 40.25. The inspection lead determines if additional areas require evaluation, based on the company’s compliance history, such as previous inspections, investigations, voluntary disclosures, compliance actions, administrative actions, legal enforcement actions, etc.

c. Each team member must bring the following inspection tools:

(1) Copy of the regulations

(2) Inspection guide (included in Appendix A of this Order)

(3) Forms (inbriefing/outbriefing sheet, witness form, Small Business Information)

(4) Laptop

(5) Office supplies (note pads, paper clips, stapler, etc.)

d. The inspection lead notifies the C&E Center Manager if additional personnel are needed or if a change in scope (e.g., comprehensive or expanded focus) is necessary.

e. Inspectors must ensure voluntary disclosure issues are addressed, as described in Chapter 4 of this order.

4. Travel Requirements. Each inspector and investigator is responsible for adhering to the following travel requirements:

a. Inspectors and investigators must adhere to the FAA Travel Policy (FAATP), which is available on the FAA’s Employee Web site and the Bargaining Unit Contract.

b. Whenever possible, inspectors and investigators will arrive in the inspection city at approximately the same time. All travel and lodging preparations must be confirmed at least one week prior to the inspection, unless precluded by schedule changes.

c. Inspectors and investigators will conserve time and fiscal resources. For instance, inspectors and investigators will lodge near inspection sites, when possible. The FAATP states, “You must exercise the same care in incurring expenses that a prudent person would exercise if traveling on personal business.” The Policy further states, “You are responsible for excess costs and any additional expenses that you incur for personal preference or convenience. FAA will not pay for excess costs resulting from circuitous routes, delays, or luxury accommodations or services unnecessary or unjustified in the performance of official business.”

d. Travel must be arranged according to the inspection team’s work plan. When exceptions occur, the inspector or investigator must notify his/her Manager or Team Coordinator. This notification may occur prior to or during travel.

5. Final Inspection Work Plan. Each inspector must submit a final inspection work plan to the C&E Center Manager, Team Coordinator(s), and secretary/program assistant of his/her Center no later than Wednesday of the week prior to inspections. The work plan will contain businesses to be inspected, along with their POCs and telephone numbers and hotel information. Service agent information will include the name of the employer or contractor associated with them. The current work plan tool is available electronically on the Drug Abatement Division’s QMS website.

6. Pre-Inspection Team Meetings. The inspection lead will hold a meeting before the inspection to help ensure a smooth, professional inspection. These meetings must occur prior to arriving at the inspection site. During the pre-inspection team meeting, the inspection lead will:

a. Provide the company’s compliance history to all members of the inspection team;

b. Assign one or more of the following inspection areas to each inspection team member: Administrative and Quality Assurance; Collection Site Review; MRO Review; SAP Review; and specific areas for Record Review.

c. Establish his/her responsibility for the inbriefing, outbriefing, and CETS entry; and

d. Confirm each inspection team member’s responsibility to inform the inspection lead immediately of any findings of noncompliance and supporting evidence or areas of concern.

7. On-Site Inspection Activities. It is critical, and mandatory under ISO procedures, to ensure that each inspection is conducted according to the Drug Abatement Division’s inspection

08/09/18 9120.1D protocol. During each inspection, the following requirements must be adhered to:

a. Conduct. All division personnel will conduct themselves professionally and must:

(1) Maintain decorum in speech, dress, and behavior;

(2) Treat their team members and company representatives with respect;

(3) Avoid socializing with any individual associated with a company’s inspection, including service agents, in accordance with the Ethics Regulations (5 CFR part 2635);

(4) Avoid discussing internal FAA activities (e.g., anticipated changes in policy, procedures, or rulemaking) with companies;

(5) Avoid discussing pending enforcement matters pertaining to current or previous inspections and investigations;

(6) Avoid conversations regarding other operators; and

(7) Bring inspection issues to the attention of the inspection lead.

b. Inbriefing. The inspection lead will conduct the inbriefing with the company and the inspection team members (see inbriefing/outbriefing guide in Figure 2-3).

(1) The inspection lead makes introductions, circulates a sign-in sheet (see meeting attendance list in Figure 2-4), explains the inspection process and distributes the Small Business information (if applicable).

(2) At the conclusion of the inbriefing, the inspection lead should announce that the next step in the process (the Administrative and Quality Assurance Interview) specifically includes the program manager or designated employer representative (DER). The inspection lead may invite others in attendance to leave, if their presence is not necessary.

c. Administrative and Quality Assurance Interview. At the conclusion of the inbriefing, the inspection lead announces the beginning of the interview phase with the company’s representative (program manager or DER) regarding the drug and alcohol testing program. To conduct the interview, each inspector must use the inspection guide found in Appendix A, Part 1. All information provided during the interview must be verified during the record review and evidence collection phase of the inspection.

d. Drug and Alcohol Testing Records Review. Records are the most common form of evidence used to verify the statements of the company’s representative. As an example, a company may provide the inspection team with a spreadsheet that includes dates of hire, transfer, and pre-employment testing. The inspection team must verify the spreadsheet information by assembling the source documents (personnel action forms, custody and control forms (CCF), etc.) that pertain to each item on the spreadsheet. The inspection team must not request the company to generate a spreadsheet for the purpose of the inspection. The inspection lead should take all documents provided by the company to support the inspection. These records must be maintained as part of the inspection record and in accordance with Appendix F of this Order.

(1) Inspection leads and team members will take part in record review activities and enter their findings in the inspection results section of CETS. Worksheets are available (see New Hire/Transfer Guide in Figure 2-5, Inspection Compliance Issue Guide in Figure 2-6, and Employee Interview Guide in Figure 2-8) to assist inspectors during record review and/or interview phases of the inspection.

(2) Inspectors/investigators are responsible for reviewing, copying, and certifying documents, as assigned by the inspection lead. The inspection lead must ensure each assigned portion of the review process is completed. Each inspector must initial the records review guide in the area of their assignments (see Part 2 of the Inspection Guide in Appendix A) to demonstrate completion. The inspection lead will enter this information into the official inspection record in CETS, and add the copies to the inspection record (in accordance with Appendix F of this Order).

(3) The inspector/investigator must certify the authenticity of evidence by providing an inspector/investigator statement as an Item of Proof to cover the entire case or each individual document. A statement is not required for evidence that is on its face self-authenticating (e.g., FAA-generated records, manuals in the FAA’s possession, emails and/or letters). Refer to Order 2150.3, as amended, Chapter 4, para. 9.g, and see Figure 2-7 of this Order for Sample Statements of Authenticity.

(4) To the greatest extent possible, all testing records must be reviewed for the time period established by the C&E Center Manager and inspection lead prior to the inspection. Depending on the circumstances, the time periods may include the past two years, since the last inspection, or the last six months.

(5) Records to review and document, if applicable, include the following categories:

(a) Positive Drug Test and Alcohol Violation Records. Inspectors/investigators must review all verified positive drug test results and alcohol violation results, except those that have already been investigated by the Special Investigations Branch (AAM-830) or should have been reported to AAM-830. Inspectors/investigators must also review the records that document the employee’s removal from a safety-sensitive function. The company has the authority to terminate or rehabilitate the employee prior to his/her return to safety-sensitive functions. If the employee is returned to safety-sensitive functions, the inspection team must review all return-toduty records. These records may include the SAP reports, SAP credentials, return-to-duty test result, and follow-up test results. If inspectors discover an individual has returned to work without completing the return- to-duty process, the inspector should address the company violation for not ensuring that the individual completed the return-to-duty process prior to allowing the individual to perform safety sensitive functions. Due to Privacy Act implications for all individuals, and even more stringent restrictions for certificate holders subject to the Pilot’s Bill of Rights (PBR), inspectors must refrain from discussing an individual’s violation. Inspectors should forward a written statement regarding the individual’s violation and copies of any documents found to the Special Investigations Branch manager’s email address or [email protected].

(b) Part 67 Medical Certificate Holders. If the company fails to report a violation involving the misuse of alcohol, or a verified positive test result by a part 67 medical certificate holder to the Federal Air Surgeon (through the Drug Abatement Division), the inspection lead

08/09/18 9120.1D should forward a written statement regarding the violation and copies of any documents found to the Special Investigations Branch manager’s email address or [email protected]. Inspectors must not investigate, comment, or discuss the alleged violation with the company or individual.

(c) Refusal Records. Inspectors must review all records concerning refusals to submit to testing, including walk-a-ways, adulterations, substitutions, etc., as defined in 49 CFR part 40. However, if the refusal was by an individual who holds a part 61, 63, 65, or 67 certificate, the matter must be referred to the Special Investigations Branch for investigation. Inspectors should forward a written statement regarding the individual’s violation and copies of any documents found to the Special Investigations Branch manager’s email address or [email protected]. The company has the authority to terminate or rehabilitate the employee prior to his/her return to safety-sensitive functions. If the employee is returned to safetysensitive functions, the inspection team must also review all return-to-duty records. It is important that the Special Investigations Branch Manager be immediately notified about a suspected failure on the part of the company to report a refusal by an airman who holds a part 61, 63, 65 or 67 FAA certificate.

(d) Return-to-Duty Testing Records. Return-to-duty tests are conducted prior to returning an employee to a safety-sensitive function after a verified positive drug test, an alcohol misuse violation, or a refusal. The objective of these tests is to ensure that those who have committed such violations are alcohol or drug-free prior to returning to the performance of safety-sensitive functions. All return-to-duty drug tests must be conducted under direct observation. Verify that the DER advises the collection site that a return-to-duty drug test is required and it must be done under direct observation. These tests occur after the SAP reports that the individual has successfully complied with the prescribed education and/or treatment. Inspectors/investigators must conduct a thorough review of these records, including: (1) documentation of the triggering event (drug positive, alcohol misuse violation, or refusal to submit to testing), (2) SAP reports (initial and follow-up evaluations, including the follow-up testing schedule) and qualifications, (3) return-to-duty CCFs/breath alcohol testing forms and verified drug test results/confirmed alcohol test results, (4) evidence that a new airman medical certificate has been issued , when applicable, and (5) documentation that the employee was returned to safety-sensitive functions and placed into the random drug and alcohol testing pool.

(e) Follow-up Testing Records. The SAP establishes a written follow-up testing plan after the individual successfully complies with his/her education and/or treatment. The required follow-up tests are conducted after an employee passes the return-to-duty test and has been returned to the performance of safety-sensitive functions. Similar to the return-to-duty testing, the objective of these tests is to ensure that individuals, who have committed violations involving the misuse of alcohol, a verified positive drug test result, or the refusal to submit to a drug or alcohol test, are compliant with the regulations governing the use of alcohol or prohibited drugs. All follow-up drug tests must be conducted under direct observation. Verify that the DER advises the collection site that a follow-up drug test is required and it must be done under direct observation. Inspectors/investigators must conduct a thorough review of these records to ensure the CCFs/breath alcohol testing forms and verified drug test results/confirmed alcohol test results match the prescribed number of tests recommended by the SAP. Keep in mind that if the employee’s employment lapses during the follow-up testing plan (e.g., they are transferred to a non safety-sensitive position or furloughed), the “plan” picks back up upon their return to duty. If you are unsure, please contact your C&E Center Manager or the Program Policy Branch Manager for further clarification.

(f) Pre-employment Testing Records. Pre-employment testing is directly tied to

08/09/18 9120.1D aviation safety, in that it is the gateway to safety-sensitive positions. Historically, preemployment testing has resulted in the highest rate of verified positive results, demonstrating that such tests are effective in detecting illegal drug use. Pre-employment alcohol testing is optional, but if a company orders an alcohol pre-employment test for one potential hire, all other new hires/transfers to safety-sensitive functions must also be preemployment alcohol tested. Pre- employment testing records could include personnel position descriptions, personnel action forms, payroll records, internal company hiring and transfer reports, CCFs, and MRO reports. In addition to reviewing the records, the inspector/investigator should interview any individual whose records, if questionable, need to clarified or confirmed. Interviews may be the only evidence available to prove a hire/transfer date, or identify other evidence to be gathered, such as maintenance logs, flight logs, or other performance documentation showing the date safety- sensitive functions were performed. Documentation of performance (whether actual or available to perform) would be used to show aggravating circumstances in an impending legal enforcement action.

(g) Random Testing Records. Random testing has three purposes: (1) to detect illegal drug use and alcohol misuse; (2) to deter employees from using illegal drugs and misusing alcohol; and (3) to remove employees engaged in such use from the performance of safety- sensitive functions. It is essential for inspectors and investigators to have thorough knowledge of what comprises a random testing program. Appendix C of this order further explores random testing regulations, including minimum annual rate, selection methodology, excusal policies and over- selection, notification and testing procedures, and testing frequency. Records that could be of use when inspecting a company’s random testing program include: (1) random drug and alcohol selection lists, (2) a listing of who was, or is, in the random pool during the covered period, (3) documentation that employees in the pool perform safety-sensitive functions (such as maintenance logs, flight logs, or other performance documentation), (4) dates employees were added or deleted, (5) notification procedures, including notifications to out-lying locations, (6) documentation of whether employees proceeded immediately to the collection site after notification of selection, (7) CCFs, (8) verified drug test results, (9) breath alcohol testing forms with the alcohol test results, and (10) verification that the company is satisfying the minimum testing rate that is published in the Federal Register.

(h) Reasonable Cause/Reasonable Suspicion Testing Records. Reasonable cause/suspicion testing is critical in the detection of employees reporting for or performing duties while having drugs and/or alcohol in their system. Companies must ensure that supervisors are trained to make a testing determination. Inspectors/investigators must review all reasonable cause/suspicion testing records, including: (1) documentation of the event that led to testing (if available), (2) documentation that the tested employee reported for or performed safety-sensitive duties (such as maintenance logs, flight logs, or other performance documentation), (3) documentation of supervisory training and the material covered, (4) CCFs, (5) verified drug test results, and (6) breath alcohol testing forms with the alcohol test results.

(i) Post-Accident Testing Records. A post-accident test occurs when an employee’s performance may have contributed to an aviation accident or cannot be completely discounted as a contributing factor to the accident. Inspectors/investigators must review all post-accident testing records including: (1) documentation of the accident, (2) information regarding the circumstances that led to the determination whether or not to test the employee, (3) CCFs, (4) verified drug test results, (5) breath alcohol testing forms with the alcohol test results, (6) documentation on why alcohol testing was not conducted within 2 hours and/or 8 hours of the accident, and (7) documentation that drug testing was conducted within 32 hours of the accident.

(j) Drug and Alcohol Records Check. Inspectors/investigators must examine all drug and alcohol records check forms during inspections, e.g., records relating to 49 CFR § 40.25, regarding whether applicants for safety-sensitive functions had a previous positive test result or refusal at another DOT employer during the past two years. This includes reviewing individual resumes and/or job applications of personnel working in safety-sensitive functions to see if the company conducted the required records checks to previous DOT employers. When reviewing a company’s requests for drug and alcohol records, inspectors/investigators must ensure that the company has made a good faith effort to obtain the records. Sending the request to a previous employer and not making a good faith effort (which includes an additional attempt) to obtain the information is unacceptable. Furthermore, unless the company has made such a good faith effort to obtain the information, the employee is not permitted to perform a safety-sensitive function after 30 days from the date on which he or she first performed a safety-sensitive function, as described in § 40.25(d).

(k) Safety Management Systems (SMS) Records. The Flight Standards Service is responsible for regulatory oversight of part 121 carriers’ safety management systems (SMS). The part 121 SMS rule (14 CFR part 5) made no changes to the drug and alcohol testing regulations, so SMS records should have no bearing on a part 121 carrier’s drug and alcohol testing program. However, if the company cites its SMS as a reason or factor in an out of compliance item, or if the inspector/investigator believes SMS records may be relevant to a particular out of compliance item, they may be reviewed. In this situation, the inspector/investigator should notify his or her manager and obtain further guidance before taking further action or providing guidance to the carrier.

Inspectors/investigators should make all attempts to interview any individual whose records need to be clarified.

e. Other Elements of an Inspection. In addition to the previous elements, the inspection is divided into the following remaining sections:

(1) Collection site and personnel. Before inspecting a collection site as part of a company inspection, the inspection team should first check CETS to see if the site has already had a comprehensive inspection within the previous 90 days. If so, the inspection team need only confirm that the collection site does conduct collections and do breath alcohol tests for that company. If not, or if an issue is discovered during record review at the company, the team should proceed to do a collection site inspection according to Appendix A, Part 3.

(2) MRO. Before inspecting an MRO as part of a company inspection, the inspection team should first check CETS to see if the company’s MRO has already had a comprehensive inspection within the previous 2 years. If so, the inspection team need only confirm that the MRO does work for that company. If not, or if an issue is discovered during record review at the company, the team should proceed to do an MRO inspection according to Appendix A, Part 4.

(3) SAP. If the company has records of return-to-duty and follow-up testing, the inspection team must contact the SAP to conduct an inspection according to Appendix A, Part 5.

f. Service Agent Issues Discovered. If any collector, laboratory, MRO, or SAP issues/discrepancies are discovered, regardless of the company, the inspector/investigator should collect all the evidence and report to the C&E Center Manager. Any egregious

04/30/19 9120.1D noncompliance discoveries should be reported to the C&E Center Manager, who must enter a Non-compliance Transmittal for the Service Agent. The C&E Center Manager and Program Administration Branch Manager must coordinate to schedule an inspection of the Service Agent. Refer to Appendix B for service agent inspections.

8. Evidence Collection. Evidence collection is the most critical element of the inspection. To prove or disprove compliance by the company, sufficient documentation must be reviewed and gathered. Inspectors/investigators must review all evidence relevant to an alleged finding of noncompliance whether it proves or disproves the suspected noncompliance by the company. Inspectors/investigators should gather all available evidence to support the finding of noncompliance, not just a single instance. This evidence must answer the questions about what happened, who was involved, and where, when, and why it occurred. The Best Evidence Checklist tool (available on the Drug Abatement Division’s (AAM-800) QMS Web site) provides guidance to inspectors/investigators when collecting evidence. When using this tool, inspectors/investigators must consider the type of company and gather the evidence necessary to establish the finding of noncompliance for that type of company. For more information concerning types of evidence typically most applicable in Drug Abatement investigations, see FAA Order 2150.3, as amended, chap. 4, para. 12.b.

The following describes different types of evidence and how each type should be handled according to Order 2150.3, as amended, chap. 4, para. 10:

a. Physical evidence. Physical evidence consists of tangible objects, such as specimen collection materials or computer software programs relating to random testing. Inspectors/investigators must exercise care in handling physical evidence so that damage, loss, or alteration does not occur. (For more information concerning physical evidence, see FAA Order 2150.3, as amended, chap. 4, para. 10.e.)

b. Witness interviews and statements. Witness interviews may be used to prove noncompliance and may be helpful in leading the inspector/investigator to other people who have direct knowledge or documentation of the issue.

(1) When possible, interview all witnesses who may be aware of a noncompliance issue.

(2) Witness accounts should be written and signed by the author, who may be the witness or the inspector/investigator. Witnesses should be informed that they are not under oath.

(3) The interview must be conducted in a professional manner with consideration for the following (see Employee Interview Guide in Figure 2-8 and Witness Statement Form in Figure 2-9):

(a) Plan the interview and questions in advance.

(b) Be attentive and take notes.

(c) Maintain control of the interview.

(d) Ask direct, relevant, and open-ended questions.

(e) Request a signed and dated statement.

(4) Inspectors and investigators will prepare a record of interview when outlining the interview/conversation conducted with witnesses or alleged violators. It should only state what the witness provided and it must not include the inspector/investigator’s personal views and/or opinions. A record of interview is necessary if a witness declines to provide a statement. Inspectors/investigators are encouraged to try to obtain witness statements that are written, signed, and dated by the interviewee. If the interviewee is unwilling to write his or her own statement, the inspector/investigator should write the interviewee’s statement and then ask the interviewee to review it for accuracy and sign and date it. If the interviewee is unwilling to do any of the above, the inspector/investigator should write the interviewee’s statement as an inspector/investigator statement and ask the interviewee to review the statement to ensure its accuracy. In the last circumstance, the inspector/investigator should document that the interviewee either affirmed the accuracy of the statement or declined to do so and that the interviewee refused to sign the statement. (For more information concerning witness interviews and statements, see FAA Order 2150.3, as amended, chap. 4, para. 10.a.)

(5) Inspector/investigator statements (see Record of Interview in Figure 2-10) are used to document findings that are not available in witness statements, technical publications, logbooks, and manuals, etc. They are also used to document a finding of noncompliance that is observed by the inspector/investigator or to capture an interview when a witness is unwilling to sign a record of interview. Inspector/investigator statements must include the date, time, location, and contact information of those present. They must be personally signed and dated by the inspector/investigator and must not include his/her personal views and/or opinions.

c. Other General Categories of Proof (i.e., Electronic Evidence, Photographs, Video, etc.). For a discussion of other common forms of evidence and how to prepare that evidence as an IOP (when necessary), see FAA Order 2150.3, as amended, chap. 4, para. 10.

9. Documentation of Inspection Results. In preparation for the outbriefing, each inspection lead will, as soon as possible, enter his/her documentation of the inspection results into CETS. The following documentation must be entered into CETS in full detail and according to current guidance in the System Rules for CETS Data Entry:

a. Update of Company Profile. Any new information concerning the company, such as additional locations, company representatives, email address, service agents, etc., must be added to its profile.

b. Outcome of Areas Reviewed and Discovered Issues. The results of an inspection should be noted with the following:

(1) Findings of noncompliance are noted when it is established that an apparent noncompliance of the regulations occurred. It is not sufficient to document only a few findings of noncompliance to show a pattern. All discovered issues must be documented, including issues that are stale. For example, if one regulatory item was out of compliance on multiple occasions, then each occasion must be listed. Documentation of each finding of noncompliance must include a full description of what happened, who was involved, where and when it occurred, and the root cause of the event (e.g., why it occurred).

(2) Concerns are noted when there are issues discovered that are not findings of noncompliance, but may lead to noncompliance if the company and/or service agent fails to

04/30/19 9120.1D resolve the issue. For example, if a collector has never dealt with a shy bladder situation, he/she may be asked to explain the shy bladder procedures as described in 49 CFR § 40.193. If the collector is unfamiliar with these procedures, this will be noted as an area of concern. It is important that the inspection lead educate the collector to the proper shy bladder procedures.

(3) Open items are noted when the issue cannot be resolved without clarification from management, or the team cannot agree on a specific item during the inspection. These items are revisited after a determination is made in coordination with the C&E Center Manager and the inspection lead.

10. Inspection Conclusion. The inspection lead will meet with the inspection team to assure that all applicable items on the inspection guide were covered and appropriate documentation was gathered, in accordance with this chapter. Inspectors must gather sufficient documentation to either demonstrate compliance or support the finding of noncompliance.

At this time the team will review and agree on all findings of noncompliance, areas of concern, or open items. If there is disagreement between the team on a particular item(s), the inspection lead must inform the company at the outbriefing that the item(s) will be left open and addressed later. The inspection lead may document the inspection results in CETS prior to the outbriefing, if time permits.

a. Outbriefing. The inspection lead is responsible for the outbriefing (see the Inbriefing/Outbriefing Guide in Figure 2-3).

(1) All members of the inspection team should attend.

(2) The inspection lead circulates the sign-in sheet for those individuals who were not part of the inbriefing (see Meeting Attendance List in Figure 2-4).

(3) If the inspection resulted in no findings of noncompliance, the inspection lead should advise the company representative that no further documentation will be received.

(4) When an inspection results in findings of noncompliance and/or areas of concern, the inspection lead must clearly and briefly identify the items discovered during the inspection. Do not linger on the issues, but explain them and obtain the company’s agreement to initiate immediate corrective action. Advise the company representative that he or she will receive a Report of Inspection letter documenting the results of the inspection and requesting written corrective action for each finding of noncompliance. If the company would like to receive the letter via electronic mail in addition to United States Postal Service (USPS) mail, certified return receipt, you should verify the email address for the President/CEO and the DER.

(5) If there are unclear items that need to be resolved with the company that were not clarified during the actual inspection, the inspection lead should do this during the outbriefing. Similarly, the inspection lead should also use this opportunity to clarify any misunderstandings about the regulations and help to educate the company. While we are responsible for training and educating the company representative, that does not remove the finding of noncompliance. Remember not to linger on the topic, but be clear and concise.

(6) Inspectors/investigators must not display any disagreement on the issues or discuss how the findings of noncompliance will be addressed (e.g., with compliance or

04/30/19 9120.1D enforcement action).

(7) The inspection team should not tell the company representative how to respond to the findings of noncompliance. It is up to the company to decide on how to take corrective action; however, it is important to make it clear that correction action is required to address all findings of noncompliance.

b. Post-outbriefing. Following the outbriefing, the inspection team should gather all records and materials and leave the company.

(1) Do not leave anything behind, including papers, folders, extraneous copies of documents. If the company created reports or documents to support your inspection, take them with you to include in the inspection file.

(2) It is not appropriate to socialize with company representatives or service agents, as this might give the appearance of a conflict of interest.

11. Post-Inspection Activities.

a. Post-inspection inspection team meeting. The inspection lead must hold a postinspection meeting with the inspectors/investigators to discuss lessons learned and to ascertain that all documentation has been gathered and certified. If the outbriefing report has already been entered into CETS, the inspection lead should have each inspector/investigator approve and initial the outbriefing report.

b. CETS. No later than seven (7) in-office working days of returning from the inspection or within the deadline assigned by the Team Coordinator and/or C&E Center Manager, each inspection lead must ensure that the information gathered is entered into CETS thoroughly and accurately, following the guidance described in the System Rules for CETS Data Entry. Specifically:

(1) Activity narrative in inspection profile;

(2) Resources tab (i.e., date and time of inspection);

(3) Updates to company information (i.e., contacts, email address, locations, etc.);

(4) Identifying the findings of noncompliance, areas of concern, and undecided or open

items;

(5) Description of each finding of noncompliance item;

(6) Analysis of the root cause of each finding of noncompliance (e.g., why the noncompliance occurred);

(7) Evidence collected;

(8) Programs tab (i.e., drug and alcohol program self-administered or C/TPA and random protocol information);

(9) Interviews (all interviewees identified and a synopsis of their statements); and

(10) When an inspection results in no findings of noncompliance, this is indicated in

CETS.

c. Inspection reporting and correspondence. Inspection reports and correspondence are prepared by the inspection lead using CETS (see Inspection Correspondence Flowchart in Figure 2- 11).

(1) Outbriefing Report. The inspection lead is responsible for entering the findings of noncompliance in CETS and generating the Outbriefing report. The inspection lead must obtain concurrence with the inspection team on the Outbriefing report.

(2) Report of Inspection (ROI) Letter. Using the letter template contained in CETS, the inspection lead is responsible for preparing a Report of Inspection (ROI) letter. The ROI describes all findings of noncompliance discovered during the inspection. The inspection lead must provide the outbriefing report, evidence to support the findings, and a draft ROI letter to the Team Coordinator and/or C&E Center Manager within seven (7) in-office working days of returning from the inspection or within the deadline assigned by the Team Coordinator and/or C&E Center Manager. The ROI letter and outbriefing report are either returned to the inspection lead for changes or approved. If the correspondence is returned to the inspection lead for changes, the review is documented under the Milestones Section in CETS and the process begins again. After the Team Coordinator and/or C&E Center Manager approve the ROI letter, the inspector must document and enter the final sign-off into CETS, in accordance with the Team Coordinator/C&E Center Manager Standards. The ROI letter must be sent to the company through United States Postal Service (USPS) mail, certified return receipt. The inspection lead may send an ADOBE pdf copy of the signed letter via electronic mail to the President/CEO and/or Designated Employer Representative and copy the Team Coordinator and C&E Center Manager.

d. Risk Analysis. Upon receiving the response to the ROI, the inspection lead is responsible for entering company information and inspection data into Drug Abatement’s Automated Risk Calculation (ARC) system, and generating a risk analysis for each finding of noncompliance. The ARC system uses a company’s compliance history, the inspection finding, evidence of noncompliance gathered during the inspection, the company’s response to immediate corrective action, system-wide data, and other relevant information to calculate the risk level, based on FAA’s safety risk management (SRM) principles as identified in Order 8040.4, as amended. For matters that are not determined an unacceptable risk to safety, the ARC incorporates guidelines, principles, and factors identified in the Drug Abatement Strategic Compliance Monitoring Plan, FAA’s Compliance and Enforcement Order 2150.3, as amended, and the FAA Compliance Program Order (Order 8000.373). The following are examples of factors used in the risk analysis:

- Corrective action and likelihood of the consequences reoccurring; - Type of behavior that resulted in noncompliance (e.g., intentional or reckless); - Compliance history (is it a repeat finding of noncompliance); - Potential severity of the consequence of noncompliance;

If the company did not respond to the ROI letter, the inspector/investigator should contact the company and encourage a response to provide corrective action. If the company continues not to respond or provide corrective action, this might, depending on the

04/30/19 9120.1D circumstances, indicate an uncooperative attitude toward compliance or an unwillingness/inability to take appropriate corrective action. A failure to respond to the ROI letter is one factor that should be taken into account as part of the risk analysis.

Taking these and other factors into consideration, the system provides the recommended action (compliance and/or administrative or legal) for each finding of noncompliance. If the inspection evidence will not support compliance, administrative, or legal enforcement action, the inspection lead must recommend that no action be taken.

The inspection lead should discuss the recommended action with the Team Coordinator or C&E Center Manager. If the inspection lead proposes deviating from the action recommended by the final ARC analysis due to mitigating factors, aggravating factors, or other information (e.g., company demographics such as size, type and/or operational experience), he/she should discuss the proposed deviation with his/her Team Coordinator or C&E Center Manager. Deviations are approved by the C&E Center Manager and elevated to the Division Manager when there is a difference of opinion.

e. Types of Recommended Action. According to Order 2150.3, as amended, the inspector or investigator has three options for addressing noncompliance.

(1) Compliance Action. Compliance action may be appropriate when the inspection lead determines that future compliance can reasonably be ensured through compliance action alone, the company displays a constructive attitude that indicates a willingness to comply, and the ARC analysis confirms that the noncompliance does not represent a high safety risk. Compliance action is not appropriate if the conduct that caused the noncompliance disclosed a lack of, or reasonable basis to question, the company’s qualifications. Compliance action is not appropriate if the criteria for legal action in Order 2150.3, as amended, are met, or when the company’s record shows past or repeated noncompliance, especially when such noncompliance is similar or related to the current noncompliance. Compliance action may not be appropriate if the company has failed to respond to the ROI letter and/or did not provide acceptable corrective action.

The inspection lead determines whether compliance action may be appropriate by reviewing the facts and circumstances of the noncompliance and completing the final ARC analysis. When the final ARC analysis supports compliance action as the appropriate action for one or more findings of noncompliance, the inspection lead determines whether the company’s corrective actions during the inspection or provided in response to the ROI letter are acceptable to resolve the issue and ensure the noncompliance does not reoccur. Compliance actions are not assigned an Enforcement Investigative Report (EIR) file number or entered into the Enforcement Information System (EIS). The compliance actions are maintained in CETS.

(2) Administrative Enforcement Action. Administrative enforcement action may be appropriate when the criteria for legal action in Order 2150.3, as amended, are not met, and the inspection lead reasonably and in good faith determines that compliance action will not remediate the noncompliance and ensure future compliance. The inspection lead makes this determination by reviewing the facts and circumstances of the noncompliance and completing the final ARC analysis. When the administrative action criteria and/or ARC analysis support administrative action as the appropriate action for an apparent violation, the inspection lead should consult with the Team Coordinator and/or C&E Center Manager before preparing the administrative action report. When administrative action is decided, CETS will assign an EIR

04/30/19 9120.1D File Number.

(3) Legal Enforcement Action. Legal enforcement action is appropriate when the criteria in Order 2150.3, as amended, are met or in circumstances where noncompliance represents an unacceptable risk to safety, as identified by Drug Abatement in published guidance based on analysis of system-wide enforcement data. Legal enforcement action may also be appropriate when the company shows a reluctance to take compliance action, or there is a pattern of repeated noncompliance that indicates an inability or unwillingness to comply with regulatory requirements. The inspection lead makes this determination by reviewing the facts and circumstances of the noncompliance and completing the final ARC analysis. When the legal action criteria and/or ARC analysis support legal action as the appropriate action for an apparent violation, the inspection lead should consult with the Team Coordinator and/or C&E Center Manager before preparing a legal enforcement report. When legal action is decided, CETS will assign an EIS File Number.

f. Action Letter (AL). The inspection lead prepares an Action Letter, using the letter template contained in CETS, after receiving the company’s response to the ROI Letter and completing the final ARC analysis. The Action Letter notifies the company which findings of noncompliance were resolved by the corrective action provided in the company’s response to the ROI letter, and which findings of noncompliance will be referred for enforcement action (if applicable). The inspection lead bases these determinations on the inspection results, the company’s response to the ROI letter, and the completed ARC analysis. If the response to the ROI indicates there is no finding, the Action Letter should indicate the finding is no longer an issue and may be considered closed. The inspection lead must provide the draft Action Letter to the Team Coordinator and/or C&E Center Manager, which is then either returned to the inspection lead for changes or approved.

If the letter is returned to the inspection lead for changes, the review is documented under the Milestones Section in CETS and the process begins again. After the Team Coordinator and/or C&E Center Manager approve the Action Letter, the inspector must document and enter the final sign-off into CETS, in accordance with the Team Coordinator/C&E Center Manager Standards. The approved Action Letter must be sent to the company within 120 calendar days from the date of the inspection or within the deadline assigned by the Team Coordinator or C&E Center Manager. The Action Letter is sent through regular United States Postal Service (USPS) mail. Electronic mail is not authorized. If enforcement action (administrative and/or legal) is included in the Action letter, the inspection lead prepares the 2150-5 form, except for the final action, and enters it into the EIS through CETS.

If the response to the ROI and evidence indicates there is no longer a finding of noncompliance for one or more issues, the inspection lead will note this in the AL and indicate that no further action is necessary pertaining to the issue(s). Separate correspondence is not necessary.

g. Legal Enforcement Action. All follow-up activities are entered into CETS. Using CETS, the inspection lead must generate the legal case and provide it to the Team Coordinator and/or C&E Center Manager within 75 calendar days from the date of inspection or within the deadline assigned by the Team Coordinator or C&E Center Manager. The legal enforcement report is either returned to the inspection lead for changes or approved. If it is returned for changes, the review is documented under the Milestones Section in CETS and the process begins again. After the Team Coordinator and/or C&E Center Manager approve the legal enforcement report, he/she must enter the final sign-off into CETS in accordance with Team

04/30/19 9120.1D Coordinator/C&E Center Manager Standards. Once the legal enforcement report is approved, the Team Coordinator or C&E Center Manager enters into CETS the date that it was sent to the Office of Chief Counsel. Through all steps, each person who reviews the file (i.e., Inspection Lead or Investigator, Team Coordinator, or C&E Center Manager) must sign and date the ARC analysis. A complete, tabbed copy of the legal enforcement action must be retained in the field office and separate from the inspection file. The inspection lead prepares the 2150-5 form, including the legal action, and sends it to EIS through CETS.

Office of the Chief Counsel or Regional Counsel will close out an issue with no action when there is insufficient evidence to prove the finding of noncompliance or apparent violation or the issue is untimely under applicable time limitation for legal enforcement actions (see FAA Order 2150.3, as amended, chap. 4, para. 5). Either situation may result in the issuance of a no action letter. If Counsel returns the case file, the Team Coordinator or C&E Center Manager will provide further instructions.

The FAA’s Compliance and Enforcement Program Order 2150.3, as amended, remains the source for inspection and investigation reporting and processing of enforcement activities. Please ensure that you continue to follow the requirements of Order 1600.75 involving “For Official Use Only” (FOUO) designations (see sample FOUO cover sheet in Figure 2-12), and the current Drug and Alcohol Compliance and Enforcement Inspector Handbook, Order 9120.1, as amended. The FOUO cover sheet template is available from the Drug Abatement Division (AAM-800) QMS Web Site and should be placed on top of the Section A tab and behind the last item of proof. All legal enforcement report folders must be prepared using a regular size brown/manila folder. There are two exceptions to this rule: 1) for cases against an individual, the folder must be red, and 2) for cases that are about to go stale, the folder must be bright blue. The top of the folder cover must include a label containing the EIS file number, name of the company (or individual), date of the violation, and the date that the violation becomes stale.

h. Administrative Action. When the final ARC analysis supports administrative action as the appropriate enforcement action for an out of compliance item or items, a letter of correction (LOC) or warning notice (WN) and Section B (Statement of Case) must be prepared for those items using the letter template contained in CETS. An LOC serves the same purpose as a WN, except the LOC is used when there is agreement with the company that corrective action acceptable to the FAA has been taken, or will be taken, within a reasonable time. The inspection lead must provide a draft of the LOC/WN and Section B to the Team Coordinator and/or C&E Center Manager within 75 calendar days from the date of inspection or within the deadline assigned by the Team Coordinator or C&E Center Manager. The LOC/WN and/or Section B is either returned to the inspection lead for changes or approved. If it is returned for changes, the review is documented under the Milestones Section in CETS and the process begins again.

After the Team Coordinator and/or C&E Center Manager approve the LOC/WN and Section B, he/she must enter the final sign-off into CETS, submit the 2150-5 to EIS, and print and sign the 2150-5 in accordance with Team Coordinator/C&E Center Manager Standards. The LOC/WN is sent to the company through USPS mail within 120 calendar days from the date of inspection or within the deadline assigned by the Team Coordinator or C&E Center Manager. Electronic mail is not authorized. The inspection lead prepares the final assembled inspection file for archiving. Through all steps, each person who reviews the file (i.e., Inspection Lead or Investigator, Team Coordinator or Center Manager) must sign and date the final ARC analysis.

i. Inspection Follow-Up Documentation. The inspection lead ensures that all follow-

04/30/19 9120.1D up activities are entered into CETS. He/she must also ensure that any follow-up information, such as documentation of additional corrective action by the company, and incoming and outgoing communication, is obtained and documented in CETS.

j. Inspection File Documentation. The final step in the inspection process is for the inspection lead to compile the inspection file documentation according to Appendix F.

Figure 2-1. Inspection Schedule Sample

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

Inspection Schedule*

This sample should be used for multiple day inspections.

Inspection Schedule*

I nspe ction Sc hedule D ay 1 November

4, 2013

Figure 2-1. Inspection Schedule Sample (cont’d)

Inspection Schedule

I

n

sp

e c

t

i

o

n

S

c

h e

d

u l

e

D a y

2

N

o

v

e m b

er 5, 2013

Figure 2-1. Inspection Schedule Sample (cont’d)

Inspection Schedule

Inspection Schedule

I

n

sp

e c

t

i

o

n

S

c h

e

d

u l e

Day 3 - 4 November 6 - 7

, 2013

Figure 2-1. Inspection Schedule Sample (cont’d)

Inspection Schedule

In

s p

e

c t i

on Sch edule Day 5 Nov

ember 8, 2013

I

n

sp e

c

ti o n

Pr o

ce s s

G u i d

e

Figure 2-2. Inspection Process Guide

Figure 2-2. Inspection Process Guide

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

Figure 2-3. Inbriefing/Outbriefing Guide

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

I n b r

i e f

i

n g

/

O u t b r i e f i n

g

G u i d e

MEETING ATTENDANCE LIST

08/09/18 9120.1D

Figure 2-4. Meeting Attendance List

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

MEETING ATTENDANCE LIST

32

M ee ting Atte ndance

List

08/09/18 9120.1D

Figure 2-5. New Hire/Transfer Guide

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

Figure 2-5. New Hire/Transfer Guide

The following guide may be used as a tool during the pre-employment record review portion of the inspection/investigation. This document

is only to help organize your results of the inspection and is not meant to be evidence to support a violation.

At the conclusion of the inspection, the inspection lead must ensure that all inspection results are captured in CETS. At that time, this

document must be destroyed and not maintained as part of the record. The CETS record is the official documentation of the inspection.

N e w

H i r

e / Transfer Gui

de

Please do not change this document without approval. All recommendations for improvement should be sent through your manager to the

Program Policy Branch Manager.

33

Figure 2-6. Inspection Finding of Noncompliance Issue Guide

Figure 2-6. Inspection Finding of Noncompliance Issue Guide

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

I n s pect i o

n F

in

ding of Noncompliance Is

sue Guide

Figure 2-7. Sample Statement of Authenticity

S

a m p l

e

S

t a t e

Figure 2-7. Sample Statement of Authenticity

m

e n t

o f A u t

h

enticity

Figure 2-8. Employee Interview Guide

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

E

m p l o

ye e

In t e

r v i e

w G u i d e

E

m

p

l o y

e

e I

n t e r v

i

e w

G

u

i d e

Figure 2-8. Employee Interview Guide (cont’d)

Figure 2-9. Witness Statement Form

Figure 2-9. Witness Statement Form

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

W i

t n e

s s

S

t a

t

e m e n t

F

orm

Figure 2-9. Witness Statement Form (cont’d)

W

i tne s s Statement Form

Figure 2-10 – Record of Interview

This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

Figure 2-10 – Record of Interview

R

e

c

o

r

d of Interview

Inspection Correspondence Flowchart

08/09/18 9120.10

Figure 2-12. Sample FOUO Coversheet This document is available electronically on our Drug Abatement Division (AAM-800) QMS Web Site.

FAA Form 1600-80 (2-05) 42 FEDERAL AVIATION ADMINISTRATION

Samp le FOUO C

Figure 2-12. Sample FOUO Coversheet

over sheet

Chapter 3. Investigations

1. General. All Drug Abatement Division activities involve elements of an investigation in which the facts of an issue are examined. The majority of these investigations pertain to alleged violations of the drug and alcohol testing regulations by companies or individuals who perform safety-sensitive functions. The purpose of these investigations is to determine whether a finding of noncompliance or apparent violation exists and warrants the need for compliance action, legal action (i.e., civil penalty or certificate action) or administrative action (i.e., WN or LOC) to ensure future compliance with the drug and alcohol testing regulations.

Chapter 3. Investigations

a. Each inspector/investigator is responsible for reporting all alleged violations to his/her manager. Based on the source and subject of the alleged violation, the investigation will be conducted by an inspector in the field or an investigator in the Special Investigations Branch (AAM-830).

b. Investigations are categorized as investigations of a company (i.e., employers, contractors, service agents) or investigations of individuals who perform safety-sensitive functions. This chapter will describe the sources of allegations, categories of investigations, and the Branch or C&E Center responsible for the investigation.

2. Sources of Allegations. An allegation may come from any of the following sources: FAA Aviation Safety Hotline, internal noncompliance transmittals (NCT), Congressional inquiries, refusal reports, part 67 reports, and complaints. Under each company’s profile in CETS, there is a tab titled “Special Issues.” This tab allows for the documentation of the source and allows for the initiation of an investigation, inspection, or a decision not to conduct a further inquiry. If an investigation is necessary, it will be initiated under the company’s activity record.

a. FAA Hotline. These allegations of safety concerns are received through the FAA’s Hotline office and directed to the Drug Abatement Division for action and may involve individuals and/or companies. Issues involving individuals are referred to AAM-830 for investigation. However, some issues involving company procedures may be assigned to the C&E Centers for inspection or investigation.

b. NCT. An NCT is an internal process that inspectors, investigators, managers, or anyone within the Drug Abatement Division may use to document issues that emerge during an inspection, an investigation, or through the course of normal duties. These issues typically involve possible noncompliance by another company or an individual. The majority of these will be handled by the C&E Centers, unless circumstances require action by AAM-830.

c. Congressional Inquiries. Congressional inquiries are correspondence requesting information regarding constituents. Congressional inquiries are referred to the Program Policy Branch (AAM-820) for action, but may be coordinated with the other Branches and the C&E Centers where necessary.

d. Refusal Reports. A company is required to report all refusals to submit to drug or alcohol testing by an individual who holds an airman certificate issued in accordance with 14 CFR parts 61, 63, 65 or 67. A company may report refusals to submit by any employee. These cases are investigated by AAM-830.

e. Verified Positive Drug Test Results/Alcohol Misuse Violations. A company is required to report all verified positive drug test results and confirmed alcohol misuse violations by any individual who holds a medical certificate issued in accordance with 14 CFR part 67. A company may report all verified positive drug test results and confirmed alcohol misuse violations by any employee. These cases are investigated by AAM-830.

f. Complaints. Complaints are the result of an individual or company requesting an investigation of an event, or information received from other FAA sources (e.g., Flight Standards Service). These allegations may be against a company or individual. These issues are referred to AAM-830 for review. AAM-830 may conduct the investigation and coordinate with the C&E Centers for assistance where necessary. It is possible that the issue may be referred to the C&E Center for inspection or investigation via a Non-compliance Transmittal Form.

3. Investigations of a Company. Investigations of a company are initiated by a Special Issue in CETS and must be initiated with a Letter of Investigation (LOI) that does not include a File Number. The response to the LOI may result in compliance and/or enforcement action depending on the ARC analysis and require an Action Letter, as described in Chapter 2 of this order. An on-site investigation at the company or one of its locations may or may not be necessary and a Branch or C&E Center Manager makes this determination.

a. Letter of Investigation (LOI). When an investigation results in an LOI, it must be prepared using the letter template contained in CETS. The LOI must describe the alleged finding of noncompliance and the assigned inspector/investigator must provide a draft LOI and background information regarding the alleged noncompliance to the Team Coordinator and/or C&E Center Manager within seven (7) in-office working days of the assigned investigation or within the deadline assigned by the Team Coordinator or C&E Center Manager. The LOI is either returned to the inspector/investigator for changes or approved. If the correspondence is returned to the inspector/investigator for changes, the review is documented under the Milestones Section in CETS and the process begins again. After the Team Coordinator and/or C&E Center Manager approve the LOI, he/she must enter the final sign-off into CETS. The LOI is then sent to the company through United States Postal Service (USPS) mail, certified return receipt. Electronic mail is not authorized. The inspector/investigator will follow the steps in Chapter 2 as it relates to getting the response, documenting the root cause, ARC and preparing the correspondence (e.g., action letter or enforcement action).

4. Investigations of Individuals Who Perform Safety-Sensitive Functions. Investigations involving individuals who perform safety-sensitive functions are critical and require an immediate investigation. All investigations of individuals are the responsibility of AAM-830 and require a LOI with a File Number. Investigations of an individual may result in either legal enforcement action or no action. Compliance and Administrative action are not used when responding to these types of investigations. These investigations most often result from the following:

a. Report of an individual’s refusal to submit to a drug or alcohol test;

b. Report of a verified positive drug test or an alcohol misuse violation by an individual who holds a medical certificate issued in accordance with 14 CFR part 67;

c. An individual performing safety-sensitive functions after testing positive or refusing to submit to a drug and/or alcohol test without complying with the return-to-duty process;

The FAA might discover the above issues through an FAA Hotline complaint or a complaint received based on the activities of an employee as they relate to drug and alcohol testing.

5. Individual Violations Discovered During Inspection. If an inspection team finds, during the normal course of an inspection, any issues that relate to violations by an individual who performs safety-sensitive functions, the inspection lead will notify the C&E Center Manager, who will subsequently notify AAM-830. The Manager of AAM-830 will provide further directions/actions and the matter should be left open.

6. Pilot’s Bill of Rights. If the individual holds an FAA-issued airman certificate (pilot, mechanic, dispatcher, etc.), the inspection team must apply the Pilot’s Bill of Rights (PBR) and follow the guidance in the January 8, 2015 Enforcement Guidance Memorandum: “Requirements for Timely, Written Notification for All Investigations of Airman Certificate Holders”. This document is available electronically on our Drug Abatement Division (AAM- 800) QMS Web Site. The Pilot’s Bill of Rights further restricts what the inspection team can and cannot do and say if it finds evidence of an individual’s violations during an inspection:

a. Do not discuss the individual’s violation with the individual or his/her company;

b. Do not engage the individual in any discussions about the apparent violations or the company’s apparent violations;

c. Address the company’s violation only (for example, its failure to ensure that its employee had completed the return to duty process before allowing the individual to perform a safety- sensitive function; or its failure to report a refusal to submit to testing);

d. Make a copy of any evidence showing the violation and refer the individual’s violation to AAM-830. Send a written statement to the AAM-830 mailbox ([email protected]) as soon as possible, including a copy of any documents you found;

e. Do not advise the company or the individual that this evidence will be reported to AAM- 830 or that an investigator will contact them.

Chapter 4. Voluntary Disclosures

Chapter 4. Voluntary Disclosures

1. General. FAA’s Compliance Program Order (Order 8000.373) recognizes that aviation safety depends primarily on voluntary adherence to the regulations. The FAA has developed the Voluntary Disclosure Reporting Program (VDRP) to encourage employers and contractors to examine their own compliance efforts. The Drug Abatement VDRP, described in Advisory Circular (AC) 120-117, allows all employers and contractors (as defined in part 120) to participate by reporting inadvertent violations to the FAA along with a description of their corrective action and comprehensive fix for preventing future violations. Records submitted to the FAA under the Voluntary Disclosure Program are protected from release to the public.

2. Procedures. The Program Administration Branch Manager will assign voluntary disclosure cases to any Drug Abatement employee for processing. When processing voluntary disclosure cases, each assigned Drug Abatement employee must use the information in this chapter, in conjunction with AC 120-117. Failure to follow these procedures may result in a nonconformity and corrective action (NCA). When an employer or contractor has a voluntary disclosure, the inspector/investigator must check the status of the voluntary disclosure during the inspection or investigation. If the disclosure is still pending, the inspector/investigator must gather evidence of the violation, immediate corrective actions, and comprehensive fix. The information should be provided to the Drug Abatement employee who is assigned to the voluntary disclosure. If the disclosure is closed, the inspector/investigator must check to ensure the comprehensive fix has been implemented. All follow-up activities should be entered in CETS.

a. Once an employer or contractor discovers an apparent violation, they may voluntarily disclose it to the FAA, ordinarily within 24 hours. The process for documentation when a disclosure is received is critical to whether it is accepted or rejected. Each Drug Abatement employee is responsible for ensuring that a disclosure is reported immediately to the appropriate Branch or C&E Center Manager.

b. An employer or contractor should submit its initial notification to disclose an apparent violation by written correspondence to the Program Administration Branch Manager. If an employer or contractor notifies an inspection lead of an apparent violation in person during an inspection or investigation, the inspector/investigator should take the information, complete his or her inspection and review of the noncompliance, and inform the employer or contractor to submit the information to the Program Administration Branch Manager as outlined in AC 120- 117. As soon as possible, the inspection lead should prepare a detailed statement of the disclosure, including the date, time of the notification, as well as the name and title of the person who provided it, and transmit everything to the C&E Center Manager and Program Administration Branch Manager.

c. After receipt of the disclosure, the Program Administration Branch Manager assigns it to a Drug Abatement employee who determines if the submission meets the conditions outlined in Section 6 of AC 120-117. If the assigned employee determines there is no violation of the regulations, the employer or contractor is advised in writing that its disclosure was not a violation using the letter template contained Drug Abatement Division’s (AAM-800) QMS web site.

d. If the disclosure meets the conditions under the VDRP, the assigned employee must

prepare a Letter of Acknowledgment (LOA) for the Program Administration Branch Manager’s signature using the letter template contained in Drug Abatement Division’s (AAM-800) QMS web site. The LOA is sent through USPS, certified return receipt or electronic mail. The LOA serves two purposes. First, it acknowledges receipt of the initial notification. Second, it identifies, in accordance with AC 120-117, the information that the employer or contractor must submit in writing to the FAA, if not already been provided. This information should be provided to the FAA within 10 working days after the initial notification was made.

e. Upon receipt of the response to the LOA, the assigned employee must analyze the violation and the information, obtain the evidence to show the violation has been corrected, and determine whether the comprehensive fix is acceptable. The determination to reject or accept a voluntary disclosure is based on specific factors of the violation and the employer or contractor’s actions. When making this determination, it is important for the assigned employee and Program Administration Branch Manager to follow the procedures established under AC 120-117 and Order 2150.3, as amended. Additionally, it is imperative to coordinate with the Drug Abatement Division Manager and Chief Counsel’s Office for disclosures that are complex or require legal guidance.

(1) If the FAA accepts the voluntary disclosure, the assigned employee prepares appropriate written correspondence for the Program Administration Branch Manager’s signature using the letter template contained in CETS. The written correspondence is sent through USPS, regular mail. At the conclusion of the disclosure process, the employer or contractor is referred for inspection so we can evaluate the comprehensive fix. The inspection lead annotates the results of his or her evaluation in CETS.

(2) If the voluntary disclosure is rejected, the assigned employee must generate written correspondence for the Program Administration Branch Manager’s signature using the letter template contained in Drug Abatement Division’s (AAM-800) QMS web site. The written correspondence is sent through USPS, certified return receipt, and the employer or contractor is referred for inspection or investigation in CETS. At the next inspection, the inspection lead should gather evidence of the violation and process inspection paperwork as if the employer or contractor had not disclosed the violation. When closing the inspection, the inspection lead will add notes to the analysis of the voluntary disclosure indicating the findings and action taken with his or her initials and the date information was entered.

f. Once the disclosure is complete, it must be included under the employer or contractor’s enforcement record in its C&E Center and CETS profile. In addition to the correspondence and evidence, the C&E Center record must include the following:

(1) Analysis. The assigned employee’s analysis must include the following (see sample analysis in Figure 4-1):

(a) Summary of the voluntary disclosure. This is a summary of the violation and the circumstances surrounding the violation. This includes a summary of the written and verbal communications to and from the employer or contractor.

(b) Summary of the employer or contractor’s comprehensive fix.

(c) List of documentation provided by the employer or contractor.

(d) Analysis and recommendation to reject or accept voluntary disclosure.

(e) Final action.

(2) Copy of the 2150-5 Form, if applicable.

FINAL ACTION:

Figure 4-1. Sample Voluntary Disclosure Analysis

VOLUNTARY DISCLOSURE ONE TWENTY ONE AIRWAYS, INC.

On January 2, 2018, One Twenty One Airways, Inc.’s Drug and Alcohol Program Manager, Brian Smith, performed an internal audit of its drug and alcohol testing program. During the audit he discovered that on November 15, 2017, One Twenty One Airways, Inc. transferred an employee, Mr. David Baker, from a non safety-sensitive position to a safety-sensitive position, but did not perform a pre-employment drug test on Mr. Smith prior to that transfer. Upon discovering this item of noncompliance, David Baker was immediately sent for a preemployment drug test. On January 3, 2018, Brian Smith notified the FAA, via written correspondence, and voluntarily disclosed the apparent violation of the drug testing regulations.

On January 5, 2018, an LOA was sent to One Twenty One Airways, Inc., via certified mail, requesting the information prescribed in AC 120-117 and a copy of Mr. Baker’s verified negative test result. On January 16, 2018, One Twenty One Airways, Inc. submitted the requested information to the FAA.

RECOMMENDATION:

A review of CETS shows that One Twenty One Airways, Inc. has not had any other violations of this nature. Based upon One Twenty One Airways Inc.’s compliance with the protocol in AC 120-117, I recommend approval of the voluntary disclosure.

FINAL ACTION:

On January 30, 2018, One Twenty One Airways, Inc. was issued written correspondence accepting their disclosure and referred to the inspection planner for a future inspection.

Chapter 5. Administrative Information

Chapter 5. Administrative Information

1. Authority to Change this Order. Practices, procedures, and documents contained in this order cannot be changed without the consent of the Drug Abatement Division Manager. Supplements to this order are prohibited unless authorized by the Drug Abatement Division Manager.

2. Background. In response to fatal aviation accidents related to substance abuse, the FAA adopted regulations in 1988 (codified as 14 CFR part 121, appendix I), which required aviation employers to implement a drug testing program for those personnel who perform safetysensitive functions. In 1994, the mandate for alcohol testing was added to 14 CFR part 121, appendix J, as a result of the investigatory findings that the Exxon Valdez oil spill of 1989 was alcohol related and that pilots of a major U.S. air carrier had flown while intoxicated in 1990. In 2009, both appendices I and J were joined to create 14 CFR part 120, Drug and Alcohol Testing Program. Upon the inception of the drug testing regulations, the Drug Abatement Division developed a comprehensive inspection program. This order has been designed to serve as a multipurpose document that will guide the inspectors and investigators in the effective implementation of the inspection program, as well as provide them with supplemental information regarding the FAA-mandated drug and alcohol testing program.

3. References. The following are references that inspectors and investigators must use to perform their jobs.

a. Code of Federal Regulations (CFR). The CFR contains the regulations implemented by each Federal agency to implement statutes passed by the United States Congress. The drug and alcohol testing regulations are located in 14 CFR part 120 and 49 CFR part 40. The CFR can be accessed online through the Government Printing Office Web site at: http://www.fdsys.gov.

b. Federal Register. The Federal Register is the official daily publication for Executive Orders, proposed rulemaking, final rules, and notices of Federal agencies and organizations. The Federal Register is published by the Office of the Federal Register, National Archives and Records Administration (NARA), and can be accessed through the Government Printing Office Web site at: http://www.fdsys.gov.

c. United States Code (USC). The USC consists of Federal statutes passed by the United States Congress. The drug and alcohol testing regulations are promulgated under the statutory authority of the Omnibus Transportation Employee Testing Act of 1991 (49 USC §§ 45101- 45107) and the FAA’s general safety authority outlined in 49 USC§§106(g) and 44701. The USC can be accessed online through the Government Printing Office Web site at: http://www.fdsys.gov.

d. Drug Abatement Division (AAM-800) QMS Web Site. This site is a part of the FAA’s Aviation Safety Quality Management System (AVS QMS) Web site. It contains AAM-800’s ISO approved processes and procedures, records, documents, and forms. This Web site can be accessed at: https://my.faa.gov/org/linebusiness/avs/programs/qms/qms_homepages/aam/qms_divisions.html.

e. FAA Drug Abatement Division Web Site. This Web site is a comprehensive source of information as it pertains to the Drug Abatement Division’s development,

04/30/19 9120.1D implementation, administration, evaluation, and compliance monitoring of the aviation industry drug and alcohol testing program described in 14 CFR part 120. This Web site can be accessed at https://www.faa.gov/go/drugabatement.

f. FAA Orders/Notices/Advisory Circulars (AC). FAA orders, such as the Compliance and Enforcement Program Order 2150.3, as amended, Compliance Program Order 8000.373, Safety Risk Management Policy Order 8040.4, as amended, and notices are directives to its own personnel and designees on how to carry out its responsibilities. ACs, such as the Voluntary Disclosure Reporting Program for Apparent Violations of the Drug and Alcohol Testing Regulations AC 120-117, are issued to provide guidance and information in a designated subject area or to show a method acceptable to the Administrator for complying with a Federal Aviation Regulation. FAA orders, notices, and ACs can be accessed online at http://rgl.faa.gov or http://isddc.dot.gov/OLPWeb.ASP.

g. Compliance Enforcement Tracking Subsystem (CETS). CETS provides the Office of Aerospace Medicine’s Drug Abatement Division with automated capabilities for tracking, scheduling, and managing enforcement activities (i.e., inspections, investigations, voluntary disclosures, and other enforcement-related activities). It also maintains a database of cases, future schedules, companies and C/TPAs, and correspondence templates. Guidance on using CETS has been published by AAM-800 in the CETS user manual and in accordance with the current guidance in the System Rules for CETS Data Entry. Inspection, investigation and voluntary disclosure correspondence must adhere to the templates included in CETS. Alternations are only permitted at the direction of the Drug Abatement Division Manager.

h. DOT Office of Drug and Alcohol Policy and Compliance (ODAPC) Web Site. The ODAPC Web site is a comprehensive source of information as it pertains to the implementation and interpretation of the drug and alcohol testing regulations in 49 CFR part 40. This Web site can be accessed at: http://www.transportation.gov/odapc.

i. Drug Abatement Division’s SharePoint Site. This site catalogues the Drug Abatement Division’s policies and guidance documents, office contacts and all program-related information. The site can be accessed at https://avssp.faa.gov/avs/aam/HQ/AAM800/SitePages/Home.aspx.

j. Safety Performance Analysis System (SPAS). SPAS is a Web-based application that tracks the performance of certificate holder—air operators, air personnel, or air agencies such as schools—and equipment such as aircraft. SPAS collects data over time to show trends and to help FAA inspectors spot anomalies. The data in SPAS comes from multiple external FAA and other government databases. SPAS can relate informational data such as Airworthiness Directives and Service Difficulty Reports.

k. Web-Based Operations Safety System (WebOPSS). WebOPSS is used by the Flight Standards Service (AFS) to collect data on operator activities, disseminate FAA policy to the certificate holder and inspector communities, and generate and manage Authorizing Documents on behalf of the operator. The system is also a repository containing some of the most up-to-date data on the airline industry.

Continue reading ↓ 120 of 204 passages shown